The U.S. central nervous system (CNS) therapeutics market, valued at USD 43.12 billion in 2024 and forecast to grow at a CAGR of 7.0% between 2025 and 2034, reflects a highly segmented ecosystem driven by innovation across treatment classes, therapeutic indications, and patient demographics. Segment-wise performance in the market is increasingly dictated by tailored product differentiation, the...
0 Commentarios
0 Acciones
208 Views
0 Vista previa
Spanish 
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek